title: Nocardia farcinica brain abscess in a patient without immunocompromise.
abstract: Brain abscess has an incidence of 1 per 100,000 in developed countries and a mortality rate of 10%. Cerebral infections with Nocardia farcinica have a mortality of up to 90%. Nocardial species are important pathogens in immunocompromised hosts, but infections in immunocompetent patients are extremely rare. We report a case of primary brain abscess with N. farcinica in a patient without immunosuppression, which was treated with surgery and a one-year course of oral moxifloxacin.
authors.affiliation: Atkinson Morley Wing, St George's Hospital, London, UK. gregfellows@gmail.com
authors.forename: G A
authors.initials: GA
authors.lastname: Fellows
authors.forename: P S
authors.initials: PS
authors.lastname: Kalsi
authors.forename: A J
authors.initials: AJ
authors.lastname: Martin
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D001922:Brain Abscess / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D024841:Fluoroquinolones; D006801:Humans; D007121:Immunocompetence; D008297:Male; D008875:Middle Aged; D000077266:Moxifloxacin; D009615:Nocardia / Q000302:isolation & purification; D009617:Nocardia Infections / Q000150:complications* / Q000188:drug therapy; D011804:Quinolines / Q000627:therapeutic use; D011859:Radiography
chemical_list: D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin